GO
Loading...

Johnson & Johnson

More

  • Early Glance: Pharmaceuticals companies Thursday, 26 Feb 2015 | 10:35 AM ET

    Baxter International Inc. fell$. 11 or. 2 percent, to $68.75. Bristol-Myers Squibb Co. fell$. 42 or. 7 percent, to $60.80. Eli Lilly& Co. fell$. 70 or 1.0 percent, to $69.66.

  • Early Glance: Medical Devices companies Thursday, 26 Feb 2015 | 10:35 AM ET

    Allergan fell $1.31 or. 6 percent, to $231.17. Baxter International Inc. fell$. 11 or. 2 percent, to $68.75. Boston Scientific Corp. fell$. 23 or 1.4 percent, to $16.69.

  • Feb 26- South Carolina's Supreme Court ordered Johnson& Johnson to pay a penalty of $136 million, upholding a jury's finding that the drugmaker's Janssen unit had improperly marketed its anti-psychotic drug Risperdal and concealed its risks. A trial court had earlier ordered J&J to pay $327 million, but the Supreme Court more than halved that penalty, citing a...

  • Feb 25- Cancer drug maker Pharmacyclics Inc is exploring a sale and has attracted interest from Johnson& Johnson and Novartis AG, Bloomberg reported. Pharmacyclics could fetch $17 billion- $18 billion from a possible sale, Bloomberg said on Wednesday, citing people familiar with the matter. A Pharmacyclics official said the company does not comment on rumors or...

  • Feb 25- Cancer drugmaker Pharmacyclics Inc is exploring a possible sale of the company and has attracted interest from Johnson& Johnson and Novartis AG, Bloomberg reported, citing people familiar the matter. Pharmacyclics could fetch $17- $18 billion from a possible sale, Bloomberg said on Wednesday. Sales of Imbruvica, which got U.S. Food& Drug Administration...

  • Midday Glance: Pharmaceuticals companies Wednesday, 25 Feb 2015 | 1:18 PM ET

    Baxter International Inc. fell$. 16 or. 2 percent, to $68.90. Bristol-Myers Squibb Co. fell$. 16 or. 3 percent, to $61.30. Eli Lilly& Co. fell$. 24 or. 3 percent, to $70.66.

  • Midday Glance: Medical Devices companies Wednesday, 25 Feb 2015 | 1:18 PM ET

    Allergan rose $1.56 or. 7 percent, to $233.39. Baxter International Inc. fell$. 16 or. 2 percent, to $68.90. Boston Scientific Corp. rose$. 24 or 1.4 percent, to $16.86.

  • Early Glance: Pharmaceuticals companies Wednesday, 25 Feb 2015 | 11:23 AM ET

    Baxter International Inc. fell$. 09 or. 1 percent, to $68.97. Bristol-Myers Squibb Co. fell$. 40 or. 7 percent, to $61.05. Johnson& Johnson fell$. 40 or. 4 percent, to $100.30.

  • Early Glance: Medical Devices companies Wednesday, 25 Feb 2015 | 11:23 AM ET

    Allergan rose $1.48 or. 6 percent, to $233.31. Baxter International Inc. fell$. 09 or. 1 percent, to $68.97. Boston Scientific Corp. rose$. 05 or. 3 percent, to $16.67.

  • Sweet! New low-cal sweetener claims better taste Wednesday, 25 Feb 2015 | 9:57 AM ET
    Dolcia Prima Allulose.

    Splenda announces corn-based natural sweetener with 90 percent fewer calories than sugar, made by British manufacturer. USA Today reports.

  • The products from South Korean firm Celltrion and its partners Hospira and Mundipharma will compete with Remicade, the original branded drug from Johnson& Johnson and Merck& Co.. Unlisted Mundipharma said on Wednesday that it is launching its biosimilar Remsima in Germany, Italy, Britain, the Netherlands, Belgium and Luxembourg, following expiry of relevant...

  • The products from South Korean firm Celltrion and its partners Hospira and Mundipharma will compete with Remicade, the original branded drug from Johnson& Johnson and Merck& Co.. Unlisted Mundipharma said on Wednesday that it is launching its biosimilar Remsima in Germany, Italy, Britain, the Netherlands, Belgium and Luxembourg, following expiry of relevant...

  • Final Glance: Pharmaceuticals companies Tuesday, 24 Feb 2015 | 6:02 PM ET

    Baxter International Inc. rose$. 42 or. 6 percent, to $69.06. Bristol-Myers Squibb Co. rose$. 16 or. 3 percent, to $61.45. Eli Lilly& Co. fell$. 19 or. 3 percent, to $70.90.

  • Final Glance: Medical Devices companies Tuesday, 24 Feb 2015 | 6:02 PM ET

    Allergan rose $1.07 or. 5 percent, to $231.88. Baxter International Inc. rose$. 42 or. 6 percent, to $69.06. Boston Scientific Corp. rose$. 31 or 1.9 percent, to $16.62.

  • Midday Glance: Pharmaceuticals companies Tuesday, 24 Feb 2015 | 1:17 PM ET

    Baxter International Inc. rose$. 27 or. 4 percent, to $68.91. Bristol-Myers Squibb Co. fell$. 10 or. 2 percent, to $61.19. Eli Lilly& Co. fell$. 26 or. 4 percent, to $70.83.

  • Midday Glance: Medical Devices companies Tuesday, 24 Feb 2015 | 1:17 PM ET

    Allergan rose$. 46 or. 2 percent, to $231.27. Baxter International Inc. rose$. 27 or. 4 percent, to $68.91. Boston Scientific Corp. fell$. 06 or. 3 percent, to $16.25.

  • Early Glance: Medical Devices companies Tuesday, 24 Feb 2015 | 11:24 AM ET

    Allergan rose$. 83 or. 4 percent, to $231.64. Baxter International Inc. rose$. 22 or. 3 percent, to $68.86. Boston Scientific Corp. rose$. 03 or. 2 percent, to $16.34.

  • Early Glance: Pharmaceuticals companies Tuesday, 24 Feb 2015 | 11:24 AM ET

    Baxter International Inc. rose$. 22 or. 3 percent, to $68.86. Bristol-Myers Squibb Co. fell$. 54 or. 9 percent, to $60.75. Eli Lilly& Co. fell$. 15 or. 2 percent, to $70.94.

  • The Biomedical Advanced Research and Development Authority has told the company that its anti-Ebola treatments should be efficient as Mapp Biopharmaceutical's ZMapp. The number of new cases has plummeted but officials have said much work still needs to be done before the virus is snuffed out in Liberia, Guinea and Sierra Leone, the three worst affected...

  • Final Glance: Pharmaceuticals companies Monday, 23 Feb 2015 | 6:04 PM ET

    Baxter International Inc. rose$. 74 or 1.1 percent, to $68.64. Bristol-Myers Squibb Co. rose$. 77 or 1.3 percent, to $61.29. Eli Lilly& Co. fell$. 79 or 1.1 percent, to $71.09.